Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1992-04-02
1994-07-26
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424401, 424489, 424499, 514 23, 514 25, 514 54, 514844, A61K 9127
Patent
active
053325753
ABSTRACT:
The invention concerns a method of binding a product to the membrane of a melanocyte by means of a ligand-receptor bond, which comprises using a product consisting of a basic structure coupled to at least one ligand consisting of an oside residue accessible to the membrane receptors, said oside residue being a fucose residue, notably an Alpha-L-fucose residue.
REFERENCES:
patent: 4377567 (1983-03-01), Geho
patent: 4386026 (1983-05-01), Ponpipom et al.
patent: 4798790 (1989-01-01), Thomson et al.
patent: 5037883 (1991-08-01), Kopecek et al.
patent: 5129877 (1992-07-01), Gallo et al.
D. Cerdan, et al., "Human Keratinocyte membrane lectins: characterization and modulation of their expression by cytokines", Biol Cell, Apr. 9, 1991, pp. 35-42.
D. Cerdan, et al., "C.sub.32 Human Melanoma Cell endogenous Lectins: Characterization and Implication in Vesicle-Mediated Melanin Transfer to Keratinocytes", Experimental Cell Research, vol. 203, Nov. 1992, pp. 164-173.
Cerdan Dominique
Kieda Claudine
Monsigny Michel
Redziniak Gerard
Kishore G. S.
Page Thurman K.
Parfums Christian Dior
LandOfFree
Method of targeting melanocytes with a compound containing a fuc does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of targeting melanocytes with a compound containing a fuc, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of targeting melanocytes with a compound containing a fuc will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1051900